Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro

Experimental Neurology
Kenjiro OnoMasahito Yamada

Abstract

Cerebral deposition of amyloid beta-peptide (Abeta) in the brain is an invariant feature of Alzheimer disease (AD). Plasma or cerebrospinal fluid concentrations of antioxidant vitamins and carotenoids, such as vitamins A, C, E, and beta-carotene, have been reported to be lower in AD patients, and these vitamins clinically have been demonstrated to slow the progression of dementia. In this study, we used fluorescence spectroscopy with thioflavin T (ThT) and electron microscopy to examine the effects of vitamin A (retinol, retinal, and retinoic acid), beta-carotene, and vitamins B2, B6, C, and E on the formation, extension, and destabilization of beta-amyloid fibrils (fAbeta) in vitro. Among them, vitamin A and beta-carotene dose-dependently inhibited formation of fAbeta from fresh Abeta, as well as their extension. Moreover, they dose-dependently destabilized preformed fAbetas. The overall activity of the molecules examined was in the order of retinol = retinal > beta-carotene > retinoic acid. Although the exact mechanisms are still unclear, vitamins A and beta-carotene could be key molecules for the prevention and therapy of AD.

References

Jul 31, 1992·Biochemical and Biophysical Research Communications·C BehlD Schubert
Jan 1, 1989·Free Radical Biology & Medicine·N I Krinsky
Apr 1, 1985·Journal of Neurochemistry·W M PardridgeW A Coty
Oct 14, 1994·Biochemical and Biophysical Research Communications·T TomiyamaN Endo
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·P McCaffery, U C Dräger
Dec 31, 1993·Brain Research·S DevR B Edwards
Nov 15, 1993·Archives of Biochemistry and Biophysics·L TesoriereM A Livrea
Sep 24, 1996·Biochemical and Biophysical Research Communications·C SotoB Frangione
Jun 1, 1997·Journal of the American Geriatrics Society·W J PerrigH B Stähelin
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·A LomakinG B Benedek
Jan 1, 1997·Journal of Neural Transmission·F J Jiménez-JiménezR Enríquez-de-Salamanca
Apr 29, 1998·The Journal of Biological Chemistry·M PappollaJ Ghiso
Jul 15, 1998·American Journal of Epidemiology·M PaleologosR Lazarus
Oct 15, 1998·Alzheimer Disease and Associated Disorders·M C MorrisD A Evans
Dec 16, 1998·International Journal of Geriatric Psychiatry·S RivièreB Vellas
Jan 13, 1999·International Journal of Geriatric Psychiatry·A J SinclairS R Maxwell
Apr 21, 1999·QJM : Monthly Journal of the Association of Physicians·C J FoyJ T Lawson
Jun 11, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F J Jiménez-JiménezJ Arenas
Oct 3, 1999·Methods in Enzymology·H Naiki, F Gejyo
Jan 19, 2000·Current Pharmaceutical Design·M I Dawson
Mar 4, 2000·Free Radical Biology & Medicine·S SchipplingU Beisiegel
Apr 29, 2000·Trends in Pharmacological Sciences·D M Skovronsky, V M Lee
Jun 13, 2000·Alzheimer Disease and Associated Disorders·C A RottkampM A Smith

❮ Previous
Next ❯

Citations

Oct 5, 2011·Experimental Brain Research·Kristina Endres, Falk Fahrenholz
Jan 8, 2014·Bioorganic & Medicinal Chemistry·Bhaskar C DasTodd Evans
May 11, 2005·Progress in Neurobiology·Michelle A Lane, Sarah J Bailey
Nov 3, 2011·Journal of Agricultural and Food Chemistry·Shigeru KatayamaSoichiro Nakamura
Apr 8, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hironobu NaikiMasahito Yamada
Nov 21, 2012·PloS One·Takehiro KikoTeruo Miyazawa
Nov 7, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yun DingGuo-Huang Fan
Mar 4, 2014·Pharmacology, Biochemistry, and Behavior·Rupinder K Sodhi, Nirmal Singh
May 8, 2013·Bioscience, Biotechnology, and Biochemistry·Mizuho SatoKazuhiro Irie
Nov 15, 2011·Brain Structure & Function·Yara Dadalti FragosoPeter J McCaffery
Jul 22, 2009·The Journal of Nutrition, Health & Aging·Y Ingenbleek
Dec 20, 2015·Journal of Alzheimer's Disease : JAD·Mrinmay ChakrabartiSwapan K Ray
Sep 29, 2012·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Asma ArfaouiMaría I Arenas
Sep 11, 2012·Trends in Neurosciences·Kirsty D ShearerPeter J McCaffery
Sep 2, 2008·Pharmacology, Biochemistry, and Behavior·Marsha M Dopheide, Russell E Morgan
Jun 17, 2008·Progress in Neurobiology·Sabien van NeervenJörg Mey
May 30, 2009·The FEBS Journal·Anna KoryakinaPeter Küenzi
Mar 16, 2012·BioFactors·Alan J LernerGemma Casadesus
Jan 10, 2012·Geriatrics & Gerontology International·Kenjiro Ono, Masahito Yamada
Apr 21, 2006·Neurobiology of Aging·Marianna ZanaJános Kálmán
Feb 8, 2006·Biochemical and Biophysical Research Communications·Kenjiro OnoMasahito Yamada
Dec 14, 2005·Neurochemistry International·Kenjiro OnoMasahito Yamada
Dec 6, 2005·Brain Research Reviews·Joana Almeida Palha, Ann B Goodman
Mar 23, 2005·Biochemical and Biophysical Research Communications·Kenjiro OnoMasahito Yamada
Feb 4, 2014·Neurobiology of Aging·Sabrina PirasMariapaola Nitti
Jun 16, 2011·Neurochemistry International·M ObulesuP V Bramhachari
Jul 19, 2016·Geriatrics & Gerontology International·Atsushi ArakiUNKNOWN Japanese Elderly Diabetes Intervention Trial Research Group
Sep 13, 2005·Biochemical and Biophysical Research Communications·Kenjiro OnoMasahito Yamada
Feb 16, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Eunyoung LeeYoungjoo Kwon
Oct 30, 2016·International Journal of Molecular Sciences·Marcus O W GrimmTobias Hartmann
Dec 23, 2016·Scientific Reports·Tanja Deckert-Gaudig, Volker Deckert
Apr 10, 2017·Biochemical Pharmacology·Paul VelanderBin Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.